Skip to content
10-Q/A

Quarterly Report

SAFECODE DRUG TECHNOLOGIES CORP.

0001144204-12-068328

← back to feed
Filed
Dec 18, 2012 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Aug 1, 2012 50M sh
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$12.71K
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$43.84K
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$9.05K
Cash And Equivalents Q2 2012 · Jun 30, 2012 $103.7K
Cash And Equivalents Q2 2012 · Dec 31, 2011 $0
Cash And Equivalents Q2 2012 · Jun 30, 2011 $0
Cash And Equivalents Q2 2012 · Dec 31, 2010 $0
Cash And Equivalents Q2 2012 · Nov 22, 2010 $0
Stockholders Equity Q2 2012 · Jun 30, 2012 $13.1K
Stockholders Equity Q2 2012 · Dec 31, 2011 −$50.62K
Stockholders Equity Q2 2012 · Dec 31, 2010 −$11.76K
Stockholders Equity Q2 2012 · Nov 22, 2010 $0
Current Liabilities Q2 2012 · Jun 30, 2012 $90.6K
Current Liabilities Q2 2012 · Dec 31, 2011 $70.62K
Total Liabilities Q2 2012 · Jun 30, 2012 $90.6K
Total Liabilities Q2 2012 · Dec 31, 2011 $70.62K
Current Assets Q2 2012 · Jun 30, 2012 $103.7K
Current Assets Q2 2012 · Dec 31, 2011 $20K
Total Assets Q2 2012 · Jun 30, 2012 $103.7K
Total Assets Q2 2012 · Dec 31, 2011 $20K
Net Income Q2 2012 · Jun 30, 2012 −$15.63K
Net Income Q2 2012 · Jun 30, 2012 −$16.28K
Net Income Q2 2012 · Jun 30, 2012 −$69.9K
Net Income Q2 2012 · Dec 31, 2011 −$41.86K
Net Income Q2 2012 · Jun 30, 2011 −$4K
Net Income Q2 2012 · Jun 30, 2011 −$10.65K
Net Income Q2 2012 · Dec 31, 2010 −$11.76K
Operating Income Q2 2012 · Jun 30, 2012 −$15.63K
Operating Income Q2 2012 · Jun 30, 2012 −$22.1K
Operating Income Q2 2012 · Jun 30, 2012 −$75.72K
Operating Income Q2 2012 · Jun 30, 2011 −$4K
Operating Income Q2 2012 · Jun 30, 2011 −$10.65K
Revenue Q2 2012 · Jun 30, 2012 $0
Revenue Q2 2012 · Jun 30, 2012 $0
Revenue Q2 2012 · Jun 30, 2012 $0
Revenue Q2 2012 · Jun 30, 2011 $0
Revenue Q2 2012 · Jun 30, 2011 $0